Trial · NCT05745337
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Exercise capacity | At time of randomization and 6 months afterwards. | Change in peak oxygen consumption during cardiopulmonary exercise testing |
| Secondary | Number of participants with a composite of treatment related adverse events | At 6 months, at 12 months, at 18 months, at 24 months | Number of heart failure hospitalization, unplanned hospitalization for atrial fibrillation, stroke or transient ischemic attack, acute coronary syndrome in both treatment arms |
| Other | Number of participants with a composite of treatment related heart failure events | At 6 months, at 12 months, at 18 months, at 24 months | Heart failure events: diuretic drug change, emergency room visit |
| Other | Number of participants with a composite of treatment related atrial fibrillation events | At 6 months, at 12 months, at 18 months, at 24 months | Atrial fibrillation events: planned hospitalization, emergency room visit, cardioversion, antiarrhythmic medication initiation |
| Other | Change in quality of life by Minnesota Living with heart failure questionnaire score | At time of randomization and 6 months afterwards. | Score ranges from 0-105 with higher scores meaning worse quality of life |
| Other | Change in quality of life by Atrial fibrillation Effect on Quality of life questionnaire score | At time of randomization and 6 months afterwards. | Score ranges from 0-100 with higher scores meaning better quality of life |
| Other | Change in NTproBNP | At time of randomization and 6 months afterwards. | |
| Other | Change in hsTroponin | At time of randomization and 6 months afterwards. | |
| Other | Change in HbA1c | At time of randomization and 6 months afterwards. | |
| Other | Change in Fructosamine | At time of randomization and 6 months afterwards. | |
| Other | Change in Cystatin C | At time of randomization and 6 months afterwards. | |
| Other | Change in atrial fibrillation burden recorded by implantable cardiac monitor | At time of randomization and 6 months afterwards. | |
| Other | Change in 6 minute walk distance | At time of randomization and 6 months afterwards. | |
| Other | Change in device detected activity level | At time of randomization and 6 months afterwards. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05745337/registered